Home/Filings/4/0001209191-19-002774
4//SEC Filing

MAUNEY DAVID M MD 4

Accession 0001209191-19-002774

CIK 0001107421other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:22 PM ET

Size

7.3 KB

Accession

0001209191-19-002774

Insider Transaction Report

Form 4
Period: 2019-01-06
MAUNEY DAVID M MD
EVP and Chief Business Officer
Transactions
  • Award

    Common Stock

    2019-01-06+159,010217,672 total
  • Award

    Employee Stock Option (right to buy)

    2019-01-06+250,733250,733 total
    Exercise: $2.24Exp: 2029-01-06Common Stock (250,733 underlying)
Footnotes (2)
  • [F1]53,004 shares shall vest on 12/31/2019 and 53,033 shares shall vest on each of 12/31/2020 and 12/31/2021.
  • [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001305832

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:22 PM ET
Size
7.3 KB